These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 21283696

  • 1. Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region.
    Zhou YH, Liu FL, Yao ZH, Duo L, Li H, Sun Y, Zheng YT.
    PLoS One; 2011 Jan 21; 6(1):e16349. PubMed ID: 21283696
    [Abstract] [Full Text] [Related]

  • 2. Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012.
    Li L, Assanangkornchai S, Duo L, McNeil E, Li J.
    PLoS One; 2014 Jan 21; 9(9):e106899. PubMed ID: 25203256
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Burmese injecting drug users in Yunnan play a pivotal role in the cross-border transmission of HIV-1 in the China-Myanmar border region.
    Chen X, Zhou YH, Ye M, Wang Y, Duo L, Pang W, Zhang C, Zheng YT.
    Virulence; 2018 Jan 21; 9(1):1195-1204. PubMed ID: 30001176
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.
    Arch Virol; 2013 Sep 21; 158(9):1889-94. PubMed ID: 23553454
    [Abstract] [Full Text] [Related]

  • 7. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS, Brajachand N, Singh HL, Singh YM.
    J Commun Dis; 2005 Mar 21; 37(1):73-7. PubMed ID: 16637404
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
    Chen F, Zhang J, Guo F, Wen B, Luo S, Yuan D, Lin Y, Ou W, Tang P, Dai G, Li F, Liu W, Qu X.
    J Gastroenterol Hepatol; 2017 Feb 21; 32(2):515-520. PubMed ID: 27248508
    [Abstract] [Full Text] [Related]

  • 9. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
    Li JR, Gong RY, Tian KL, Wang J, Wang YX, Huang HJ.
    World J Gastroenterol; 2007 Apr 28; 13(16):2357-62. PubMed ID: 17511038
    [Abstract] [Full Text] [Related]

  • 10. Systematic review of HIV and HCV infection among drug users in China.
    Bao YP, Liu ZM.
    Int J STD AIDS; 2009 Jun 28; 20(6):399-405. PubMed ID: 19451325
    [Abstract] [Full Text] [Related]

  • 11. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA, Dirgahayu P, Sari Y, Hudiyono H, Kageyama S.
    J Infect Dev Ctries; 2013 Jun 15; 7(6):453-67. PubMed ID: 23771289
    [Abstract] [Full Text] [Related]

  • 12. Multiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China's HIV/HCV Epidemics.
    Chen M, Ma Y, Chen H, Luo H, Dai J, Song L, Yang C, Mei J, Yang L, Dong L, Jia M, Lu L.
    PLoS One; 2015 Jun 15; 10(11):e0142543. PubMed ID: 26562015
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.
    Eur J Epidemiol; 1998 Sep 15; 14(6):555-61. PubMed ID: 9794122
    [Abstract] [Full Text] [Related]

  • 15. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M.
    BMC Infect Dis; 2006 Jun 08; 6():93. PubMed ID: 16762050
    [Abstract] [Full Text] [Related]

  • 16. Influence of interleukin 10 polymorphisms -592 and -1082 to the HIV, HBV and HCV serostatus among intravenous drug users.
    Kallas E, Huik K, Pauskar M, Jõgeda EL, Karki T, Des Jarlais D, Uusküla A, Avi R, Lutsar I.
    Infect Genet Evol; 2015 Mar 08; 30():175-180. PubMed ID: 25542814
    [Abstract] [Full Text] [Related]

  • 17. Plasma Virome Reveals Blooms and Transmission of Anellovirus in Intravenous Drug Users with HIV-1, HCV, and/or HBV Infections.
    Li Y, Cao L, Ye M, Xu R, Chen X, Ma Y, Tian RR, Liu FL, Zhang P, Kuang YQ, Zheng YT, Zhang C.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0144722. PubMed ID: 35758682
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A, Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Strathdee SA, Tjaden J.
    Int J Drug Policy; 2011 Mar 31; 22(2):145-52. PubMed ID: 21146392
    [Abstract] [Full Text] [Related]

  • 19. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
    Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L.
    Lancet; 2011 Aug 13; 378(9791):571-83. PubMed ID: 21802134
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.